Targeting kinases in CML CLL
- PMID: 20864583
- DOI: 10.1182/blood-2010-07-289900
Targeting kinases in CML CLL
Comment on
-
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.Blood. 2010 Sep 23;116(12):2078-88. doi: 10.1182/blood-2010-02-271171. Epub 2010 Jun 3. Blood. 2010. PMID: 20522708 Free PMC article.
Similar articles
-
Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.Int J Surg Pathol. 2020 Apr;28(2):216-224. doi: 10.1177/1066896919876704. Epub 2019 Sep 22. Int J Surg Pathol. 2020. PMID: 31544558
-
[A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].Gan To Kagaku Ryoho. 2011 Feb;38(2):333-6. Gan To Kagaku Ryoho. 2011. PMID: 21368508 Review. Japanese.
-
Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).Int J Hematol Oncol Stem Cell Res. 2014 Oct 1;8(4):49-53. Int J Hematol Oncol Stem Cell Res. 2014. PMID: 25774268 Free PMC article.
-
The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.Rom J Morphol Embryol. 2015;56(3):1145-51. Rom J Morphol Embryol. 2015. PMID: 26662151 Review.
-
Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.Clin Lab. 2014;60(11):1929-32. doi: 10.7754/clin.lab.2014.140315. Clin Lab. 2014. PMID: 25648037
Publication types
LinkOut - more resources
Full Text Sources